GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.660
-0.020 (-0.54%)
At close: Aug 10, 2026, 4:00 PM EDT
3.589
-0.071 (-1.93%)
After-hours: Aug 10, 2026, 7:55 PM EDT

GoodRx Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
785.23796.85792.32750.27766.55745.42
Revenue Growth
-1.83%0.57%5.61%-2.13%2.83%35.36%
Gross Profit
713.19739.26744.11683.34701.48698.71
Operating Income
74.9487.4965.85-27.011.7413.41
Net Income
16.2530.4416.39-8.87-32.83-25.25
Earnings Per Share
0.040.090.04-0.02-0.08-0.06
EPS Growth
-60.00%125.00%----

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Prescription Transactions
472.1544577.55550.74550.54593.36
Subscription
95.2183.7986.5494.4196.1759.93
Pharma Direct
201.61151.38107.2485.0799.4373.35
Other Service
16.3117.692120.0520.4318.79
Revenue (Total)
785.23796.85792.32750.27766.55745.42

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
296.11261.82448.35672.3757.17941.11
Total Debt
538.95542.81543.39711.07717.02702.33
Net Cash (Debt)
-242.84-280.99-95.04-38.7740.14238.78
Net Cash Growth
-----83.19%-9.47%
Net Cash Per Share
-0.70-0.79-0.24-0.090.100.58

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
201.58167.9183.89138.29146.78178.78
Capital Expenditures
-4.49-3.52-1.24-1.04-3.97-4.57
Free Cash Flow
197.09164.38182.65137.25142.81174.21
Free Cash Flow Growth
4.01%-10.00%33.08%-3.90%-18.02%57.24%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.83%92.77%93.91%91.08%91.51%93.73%
Operating Margin
9.54%10.98%8.31%-3.60%0.23%1.80%
Pretax Margin
5.27%7.10%3.97%-7.41%-3.03%-1.37%
Profit Margin
2.07%3.82%2.07%-1.18%-4.28%-3.39%
FCF Margin
25.10%20.63%23.05%18.29%18.63%23.37%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
77.1130.11116.25---
Forward PE
31.0418.8527.04186.56167.96267.21
P/FCF Ratio
6.345.629.7519.2412.9675.14
PS Ratio
1.591.162.253.522.4117.56